Celgene to give oral presentations on beta-thalassemia.

Acceleron, Celgene to give oral presentations on beta-thalassemia, myelodysplastic syndromes at EHA meeting Acceleron Pharma Inc. , a medical stage biopharmaceutical company focused on the discovery, commercialization and development of novel protein therapeutics for cancers and rare diseases, today reported that Acceleron, Celgene and investigators in the sotatercept and ACE-536 phase 2 scientific trials gives three oral presentations of interim data from ongoing research in beta-thalassemia and myelodysplastic syndromes as well as a poster presentation of non-clinical data in sickle cell disease at the 19th Annual Congress of the European Hematology Association in Milan, Italy from June 12-15, 2014.Injuries cost Americans far too much money, suffering and preventable death, CDC Director Dr. Tom Frieden said in an agency news discharge. The doubling of deaths by medication poisoning, including prescription drug heroin and overdose, is particularly alarming. Men accounted for 78 % of fatal injuries and 63 % of nonfatal injury costs in 2013. Over fifty % of the medical and work loss costs of fatal accidental injuries had been from accidents , accompanied by suicide and murder . Prescription medication overdoses and other medication poisonings accounted for the most fatal injury costs , accompanied by transportation-related deaths and gun-related deaths .